期刊文献+

盖诺联合化疗治疗非小细胞肺癌近期疗效观察 被引量:21

Homemade vinorelbine based combination chemotherapy in non - small cell lung cancer
下载PDF
导出
摘要 目的:观察国产去甲长春花碱(盖诺)联合顺铂化疗治疗非小细胞肺癌的疗效和安全性。方法:用NP方案:盖诺25mg/m2 d1、8,DDP80~100mg/m2 d1。21天为1周期,至少治疗2周期。治疗28例非小细胞肺癌。结果:OR:46.4%,初治者OR高达50.0%,复治者为25.0%;毒副作用以白细胞减少和恶心、呕吐为常见。结论:盖诺联合顺铂治疗非小细胞肺癌疗效明显,耐受性好。 Objective:To evaluate the efficacy and toxicity of home made vinorelbine plus cisplatin combination chemotherapy in treating non- small cell lung cancer. Methods: From April 2000 to February 2001, 28 cases received vinorelbine 25mg/m dl,8; cisplatin 80-100mg/m d 1 combination chemotherapy. Results: The overall response rate (OR) for the whole patients was 46.4% . In the chemotherapy the OR of naive patients was as high as 50.0 % ; while in those with prior chemotherapy, the OR was obtained only in 25.0% . The most commonly side-effects of the agent were leukopenia and vomiting with frequencies of 92.8% and 64.3% respectively.Conclusion:Home made vinorelbine is a rather active in treating malignant carcinoma with acceptable tolerance.
出处 《临床肿瘤学杂志》 CAS 2001年第3期274-275,共2页 Chinese Clinical Oncology
关键词 去甲长春花碱 顺铂 非小细胞肺癌 化疗 盖诺 Vinorelbine Cisplatin Non-small cell lung cancer Chemotherapy
  • 相关文献

参考文献5

二级参考文献5

  • 1Zhou X J,Drugs,1992年,44卷,增4期,1页
  • 2潘启超,国外科技,1990年,33卷,39页
  • 3管忠震,癌症,1993年,12卷,217页
  • 4张湘茹,北京医学,1992年,14卷,171页
  • 5P. Boré,R. Rahmani,J. Cantfort,C. Focan,J. P. Cano. Pharmacokinetics of a new anticancer drug, navelbine, in patients[J] 1989,Cancer Chemotherapy and Pharmacology(4):247~251

共引文献725

同被引文献59

  • 1韩福才,杨卫华,周华,朱海波,郭沁香,郭伟.NP和CAP方案治疗晚期NSCLC的对比研究[J].肿瘤研究与临床,2001,13(3):173-175. 被引量:2
  • 2潘启超.长春碱类的新进展──失碳长春碱[J].癌症,1996,15(3):228-231. 被引量:276
  • 3江泽飞,宋三泰,徐建明,刘晓晴,李彦博,赵平瑜.单用去甲长春花碱治疗复发转移乳癌[J].中华肿瘤杂志,1996,18(3):208-210. 被引量:45
  • 4杨荣强 王柏生 等.羟基喜树碱治疗晚期非小细胞肺癌32例临床评估[J].中国肿瘤临床,2000,27:55-57.
  • 5刘怀深.卡铂腹腔化疗研究[J].中国肿瘤临床与康复,2001,5:212-213.
  • 6[1]Bell DR. Drug treatment of lung cancer. Medical Progress,1998,3(1)∶36-40.
  • 7[2]Hsiang YH, Liu LF. Identification of mammalian DNA topoisomerase Ⅰ as an intracellular target of the anticancer drug camptothecin.Cancer Res,1988,48(7)∶1722-1726.
  • 8[5]Lechvalier T, Brigarnd D, Doullard JY, et al. Randomized study of VRB and cisplatin versus vindesize cisplatin versus VRB alone in advanced NSCLC: Result of a Europen multicenter treal including 612 Oucd. J Clin Patients,1994,12(3)∶6007.
  • 9David R Bell. Drug treatment of lung cancer.Medical Progress, 1998, 3 (1) :36.
  • 10Hsiang YH. Identification of mammalian DNA topoisomerase I as an intracelelular target of the anticancer drug camptothecine. Cancer Res,1988, 48:1722.

引证文献21

二级引证文献34

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部